China
HUMAN celebrates its 50th anniversary
From reagent specialist to global player with a broad network of long-standing distribution partners in more than 160 countries • Covering a compre...
December 05, 2022 | News
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi city site
This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...
December 01, 2022 | News
WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility
WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...
November 24, 2022 | News
The 13th China (Taizhou) International Medical Expo successfully held
During the event, 20 projects with a total investment of about 7.1 billion yuan were signed intensively, covering fields such as vaccines, antibo...
November 24, 2022 | News
Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the Investigational New Drug (IND) application by China National Medical Prod...
November 17, 2022 | News
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The vaccine incorporates five distinct RSV antigens...
November 15, 2022 | News
Mednovation Entered Into Strategic Cooperation With LSI
Under the agreed arrangement, which is effective as of this release, Mednovation shall be the preferred partner of LSI for its partnering events, seminars,...
November 15, 2022 | News
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...
November 14, 2022 | News
XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics
Xi'an Jiaotong-Liverpool University (XJTLU) researchers conduct world-class biopharmaceutical research at the University's Suzhou Industrial Park (SIP) c...
November 09, 2022 | News
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled HTBA3011 Undif...
November 09, 2022 | News
Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China
Merck to offer its first-to-market Blazar ® Rodent Panel for virus testing Reduces biosafety turnaround time by up to 80% Reduces animal ...
November 08, 2022 | News
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
November 07, 2022 | News
NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is announc...
November 03, 2022 | News
Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery
The operation was performed by the team of Professor and Dr. Xiaofeng Zhang, vice president of Hangzhou First People's Hospital and director of the Ce...
November 03, 2022 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
